Implant Sciences Corp. (OTC: IMSC) is a leader in advancing trace detection capabilities to address evolving security problems. Implant Sciences’ non-radioactive ion mobility spectrometry systems have been deployed in more than 50 nations worldwide for aviation security, infrastructure protection, mass transit security, military operations, VIP protection, and corporate security. The QS-B220 desktop explosives and drugs trace detector is the first ETD to meet the standards of both TSA and ECAC. The QS-B220 uses Ion Mobility Spectrometry to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. For more information, visit the company’s website at www.implantsciences.com